Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

BACKGROUND: Olanzapine long-acting injection (LAI) is a salt-based depot antipsychotic combining olanzapine and pamoic acid. The slow intramuscular dissolution of this practically insoluble salt produces an extended release of olanzapine lasting up to 4 weeks. However, in a small number of injection...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonnell, David P, Detke, Holland C, Bergstrom, Richard F, Kothare, Prajakti, Johnson, Jason, Stickelmeyer, Mary, Sanchez-Felix, Manuel V, Sorsaburu, Sebastian, Mitchell, Malcolm I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895590/
https://www.ncbi.nlm.nih.gov/pubmed/20537130
http://dx.doi.org/10.1186/1471-244X-10-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895590/
https://www.ncbi.nlm.nih.gov/pubmed/20537130
http://dx.doi.org/10.1186/1471-244X-10-45

Ejemplares similares